分子光谱市场预计将从 2022 年的 38.073 亿美元增长到 2030 年的 55.8637 亿美元;预计 2022-2030 年期间的复合年增长率为 4.9%。
市场洞察和分析师观点:
分子光谱市场预测可以帮助该市场的利益相关者规划他们的增长战略。
分子光谱的普及和使用以及制药行业的快速增长等因素推动了分子光谱市场的增长。然而,技术人才的短缺以及高昂的维护和安装成本阻碍了市场的增长。
增长动力:
制药行业快速增长推动分子光谱市场
近年来,制药业经历了前所未有的增长速度,预计未来几年将进一步发展。美国制药研究和制造商协会 (PhRMA) 表示,美国公司承担了全球一半以上的药品研发工作(750 亿美元),并拥有最多的新药专利。除了发达经济体外,巴西、中国和印度等新兴经济体的研究环境也出现了快速增长。
制药行业的增长对于增加对分子光谱的需求也至关重要。分子光谱技术,包括红外光谱、紫外可见光谱和质谱,是药物研发的最重要工具之一。近年来,制药行业的大幅扩张(主要是由于 COVID-19 疫情)对分子光谱市场规模产生了积极影响。
分子光谱在制药行业的主要应用是分析分子键强度、识别分子内的单个键和特定原子、获取分子特定方向的线索以及分析药理纯度。随着制药公司扩大与药物发现和开发相关的研发活动,对分子光谱的需求正在显著增加。例如,拉曼光谱用于研究结构活性和相互作用,以改进反应条件和配方筛选,并识别从发现到开发过程中的多晶型和规模化药物化合物等限制因素。
因此,上述因素增加了各种治疗药物大规模生产对分子光谱的需求,促进了分子光谱市场份额的扩大。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
分子光谱市场:
复合年增长率(2022 - 2030 年)4.9%- 2022 年市场规模
38.1 亿美元 - 2030 年市场规模
55.9 亿美元
市场动态
- 分子光谱学的采用和使用日益广泛
- 药物发现和研发增加
- 核磁共振波谱法的应用日益广泛
关键人物;主力;重要一员
- 赛默飞世尔科技公司
- 默克公司
- 珀金埃尔默公司
- 安捷伦科技公司
- 布鲁克
- 堀场制作所
- 岛津制作所
- 日本电子株式会社
- 日本分光
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 仪器及配件
- 紫外可见光谱
- 红外光谱
- 核磁共振波谱
- 拉曼光谱
- 近红外光谱
- 其他的
- 学术和研究应用
- 生物技术应用
- 制药应用
- 其他的
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告细分和范围:
“分子光谱市场分析”是从产品、技术和应用三个部分考虑的。
节段分析:
根据技术,分子光谱市场细分为紫外可见光谱、红外光谱、核磁共振光谱、拉曼光谱、近红外光谱等。紫外可见光谱部分在 2022 年占据了最大的市场份额。预计核磁共振光谱部分在预测期内的复合年增长率最高,为 6.0%。
紫外-可见 (UV-Vis) 光谱法是一种测量样品吸收或透射的紫外线或可见光的波长数量(与参考或空白样品相比)的方法。紫外-可见光谱法是一种广泛用于各种科学领域的方法,包括细菌培养、药物鉴定、核酸纯度测试和定量、饮料行业的质量控制和化学研究。
核磁共振 (NMR) 光谱法是一种分析化学程序,用于质量控制和研究,以揭示样品的含量、纯度和分子结构。除了分子结构之外,NMR 光谱法还可以确定相变、构象和配置变化、溶解度和扩散潜力。二十五年多来,NMR 光谱法已广泛应用于制药行业,用于确定化学样品的结构。如今,NMR 越来越多地用于解决生物问题。所使用的技术范围从生物液体 NMR 到灌注器官和整个动物的体内 NMR 光谱法,再到整个动物和人类的 MRI 。
分子光谱市场按产品分为仪器和配件。仪器部分在 2022 年占据了更大的市场份额,预计在预测期内将实现 5.1% 的更高复合年增长率。光谱仪可根据工作原理分为三种主要类型:色散型、基于滤波器的和傅里叶变换仪器。在过去几十年中,傅里叶变换光谱仪 (FTS 或 FT 光谱仪) 已在许多红外和近红外应用中取代了色散型仪器。干涉仪是每个傅里叶变换光谱仪的核心。当前一代 FT 光谱仪使用各种干涉仪设计。
分子光谱市场按应用分为学术和研究应用、生物技术应用、制药应用和其他。学术和研究应用领域在 2022 年占据了最大的市场份额,预计在预测期内将实现最高的 5.4% 复合年增长率。学术和研究机构是分子光谱市场的关键贡献者,尤其是那些从事生物技术、细胞培养和再生医学的机构。这些机构是关键的测试和验证中心,对各种产品的生物相容性和可扩展性进行细致评估。
研究和开发组织致力于创新、推出新产品和新技术以及在分子光谱市场提供服务的过程和活动。研究和开发对于加速产品推出也很重要。研究和开发组织的增长主要归因于生物反应器在研究和创新过程中的日益普及。此外,研究机构投入巨资来促进生物过程,从而推动市场增长。
药物研发新兴趋势加速分子光谱市场扩张
在 COVID-19 大流行期间,对分子光谱的需求和使用显著增加。2022 年 7 月,Bruker PhenoRisk 推出了 PACS RuO,这是一种仅用于研究的 NMR 测试,用于对“长期 COVID-19”患者的血液样本进行分子表型研究。PhenoRisk PACS RuO 测试有望探索早期风险因素、监测纵向恢复情况以及心血管疾病、II 型糖尿病、炎症和肾功能障碍中的潜在继发性器官损伤。
此外,分子光谱在药物发现和开发中起着至关重要的作用。拉曼光谱已被证明是药物发现和药物开发最强大的分析技术之一。2020 年 9 月,一家美国华人生物科技公司 Xtalpi 筹集了 3.19 亿美元的资金,以进一步开发其智能数字药物发现和开发平台 (ID4),其中包括固体形状选择、预测小分子候选物性质和其他服务。因此,药物发现的进步可能会在未来几年带来新的分子光谱市场趋势。
区域分析:
从地理上看,全球分子光谱市场报告分为北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了最大的分子光谱市场份额。该地区市场的增长得益于生物技术和生物制药公司推出的产品数量不断增加以及主要市场参与者的存在。此外,各制药和生物技术公司以及学术和研究机构的广泛研发预计将刺激北美分子光谱市场的增长。
美国是北美市场最大的贡献者。这主要由不断增长的生物制药行业推动,该行业的特点是技术进步和灵活性不断提高。根据国际贸易管理局 (ITA) 的数据,美国是全球生物制药研发领域的领导者。由于监管机构批准的新分子实体 (NME) 数量不断增加,以及一些市场参与者提供新产品,新生物制剂取得了重大发展,有助于创造新的市场趋势。据《化学与工程新闻》报道,美国食品药品管理局 (FDA) 每年批准的 NME 数量不断增加。此外,美国制药和生物技术公司增加研发投资以改善临床试验结果并确保患者安全,刺激了市场增长。
在加拿大,许多制药公司在全球市场上提供创新产品,这促进了分子光谱市场的增长。在加拿大运营的此类公司包括安进、Xenon Pharmaceuticals、Zymeworks、吉利德科学、雅培、Alphora Research、安进、Apotex、安斯泰来、默克、AbbVie、百时美施贵宝、Caprion Biosciences、Charles River Laboratories、葛兰素史克、Pharma、阿斯利康、百特、拜耳和 Cipher Pharmaceuticals。
生物制药行业在加拿大的卫生研究和创新生态系统中至关重要。此外,制药公司通过合作开展的广泛研发活动引发了对中小企业 (SME) 和风险基金的额外投资。此外,为加拿大和国际客户提供服务的合同研究组织和合同制造组织 (CRO 和 CMO) 数量不断增加,扩大了加拿大制药行业的范围,从而对市场增长产生了积极影响。2021 年 8 月,加拿大政府宣布与领先的 COVID-19 疫苗开发商 Moderna, Inc. 达成协议,在加拿大建立 mRNA 疫苗工厂。最近宣布的生物制造和生命科学战略的目标与 Moderna 在加拿大建立 mRNA 疫苗制造工厂的努力相一致。此举将增强加拿大的工业能力并促进生物制造和生命科学行业的发展。
分子光谱市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 38.1亿美元 |
2030 年市场规模 | 55.9亿美元 |
全球复合年增长率(2022 - 2030 年) | 4.9% |
历史数据 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
行业发展和未来机遇:
以下列出了分子光谱市场主要参与者的一些战略发展:
- 2023 年 3 月,NJ Biopharmaceuticals LLC 和 JEOL Ltd. 宣布合作,利用 JEOL 的 800 MHz NMR 提供创新药物发现平台解决方案。NJ Bio 贡献其在抗体-药物偶联物、寡核苷酸偶联物和其他化学方面的专业知识,为其药物发现客户开发平台解决方案,特别是使用 NMR 衍生的结构信息来优化靶向蛋白质降解剂 (TPD) 的平台。
- 2023 年 12 月,用于生命和材料研究的 NMR 光谱解决方案主要由布鲁克公司提供,该公司宣布在俄亥俄州立大学国家网关超高场 NMR 中心成功安装了 1.2 GHz NMR 系统。可以进行高分辨率液体和固态 NMR 研究的现代设备是 1.2 GHz AVANCE NMR 光谱仪。俄亥俄州立大学和美国各地的研究人员将使用它来研究生物分子的结构和动力学以及尖端材料(例如电池中使用的材料),以更好地了解癌症、心脏病、病毒感染和阿尔茨海默病等疾病的根本原因。
- 2023 年 12 月,精密仪器、测量仪器和医疗设备的领先制造商岛津公司发布了 IRSpirit-X 系列傅里叶变换红外 (FTIR) 分光光度计,包括 IRSpirit-LX、IRSpirit-TX 和 IRSpirit-ZX。入门级 IRSpirit-LX 和 IRSpirit-TX 对小型 FTIR*3 具有最高灵敏度,而 IRSpirit-ZX 由于具有更耐潮的组件,因此能够在高温和高湿度地区进行稳定测量。
- 2023 年 12 月,岛津公司推出了 GCMS-QP2050 四极杆气相色谱质谱仪。气相色谱质谱仪 (GC-MS) 通过在原子和分子水平上进行分离来分析样品中化学物质的类型和数量。GC-MS 系统用于检测农药和其他受控环境污染物,以及食品和化学产品的质量控制和商业开发。
竞争格局和重点公司:
Bruker Corporation、Jasco Corp、Shimadzu Corp、JEOL Ltd、Teledyne Princeton Instruments Inc、Agilent Technologies Inc、Oxford Instruments Plc、Ostec Instruments、Revvity Inc、Merck KGaA、Silios Technologies SA、Thermo Fisher Scientific Inc 和 Horiba Ltd 是分子光谱市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Thermo Fisher Scientific Inc and Agilent Technologies Inc are the top two companies that hold huge market shares in the molecular spectroscopy market.
Global molecular spectroscopy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America regional market is expected to grow with a CAGR of 5.1% during 2022–2030. Market growth in this region is attributed to the increasing number of product launches by biotechnology and biopharmaceutical companies and the presence of key market players. In addition, extensive R&D by various pharmaceutical and biotechnology companies and academic & research institutes is expected to stimulate the North America molecular spectroscopy market growth.
The molecular spectroscopy market majorly consists of the players such Bruker Corporation, Jasco Corp, Shimadzu Corp, JEOL Ltd, Teledyne Princeton Instruments Inc, Agilent Technologies Inc, Oxford Instruments Plc, Ostec Instruments, Revvity Inc, Merck KGaA, Silios Technologies SA, Thermo Fisher Scientific Inc, and Horiba Ltd.
The academic and research applications segment dominated the global molecular spectroscopy market and held the largest market share of 41.9% in 2022.
The CAGR of the molecular spectroscopy market during the forecasted period of 2022-2030 is 4.9%.
The instruments segment held the largest market share of 85.3% in 2022.
Key factors that are driving the growing adoption and use of molecular spectroscopy and the rapid growth of the pharmaceutical industry.
Molecular spectroscopy is used in the R&D of pharmaceuticals and other biotechnological products. Near-infrared (NIR) spectroscopy is one of the types of molecular spectroscopy that has gained wide recognition in the pharmaceutical industry in recent years due to its huge advantages over other analysis techniques; it helps in effortless sample preparation and exhibits the ability to obtain chemical and physical sample parameters from a single spectrum. Raman spectroscopy is also one of the powerful analytical techniques implemented in drug discovery and pharmaceutical development. It is used to study structural activity relationships and improve reaction conditions and other parameters, such as polymorph and formulation screening, that lead to the scale required to move drug compounds from discovery to development.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Molecular Spectroscopy Market
- Thermo Fisher Scientific, Inc
- Merck KGaA
- PerkinElmer Inc.
- Agilent Technologies, Inc
- Bruker
- Horiba, Ltd
- Shimadzu Corporation
- JEOL Ltd
- JASCO
- Oxford Instruments
- Teledyne Princeton Instruments
- SILIOS Technologies
- Ostec Instruments
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.